WallStreetZenWallStreetZen

NASDAQ: IMVT
Immunovant Inc Stock Ownership - Who owns Immunovant?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Immunovant Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Peter SalzmannChief Executive Officer2025-04-168,321$14.89
$123.90kSell
Eva Renee BarnettChief Financial Officer2025-04-162,993$14.89
$44.57kSell
Eva Renee BarnettChief Financial Officer2025-04-097,013$12.99
$91.10kSell
Michael GeffnerChief Medical Officer2025-04-096,169$12.99
$80.14kSell
Jay S. StoutChief Technology Officer2025-04-095,004$12.99
$65.00kSell
Peter SalzmannChief Executive Officer2025-04-0928,094$12.99
$364.94kSell
Eva Renee BarnettChief Financial Officer2025-04-094,050$12.99
$52.61kSell
Andrew J. FromkinDirector2025-03-076,616$19.52
$129.14kSell
Andrew J. FromkinDirector2025-03-071,384$19.96
$27.62kSell
Eva Renee BarnettChief Financial Officer2025-02-192,814$20.86
$58.70kSell

1 of 8

IMVT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IMVT insiders and whales buy or sell their stock.

IMVT Shareholders

What type of owners hold Immunovant Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Roivant Sciences Ltd56.90%96,650,341$1.46BInsider
Fmr LLC7.71%13,097,915$198.43MInstitution
Vanguard Group Inc3.93%6,679,414$101.19MInstitution
Deep Track Capital LP3.53%6,000,000$90.90MInstitution
Blackrock Inc3.03%5,143,071$77.92MInstitution
T Rowe Price Investment Management Inc3.01%5,117,234$77.53MInstitution
Alpine Global Management LLC2.54%4,317,808$65.41MInstitution
Armistice Capital LLC2.28%3,870,586$58.64MInstitution
State Street Corp1.59%2,697,522$40.87MInstitution
Perceptive Advisors LLC1.26%2,139,199$32.41MInstitution

1 of 3

IMVT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IMVT44.70%55.30%Net BuyingNet Selling
ACAD71.61%28.39%Net SellingNet Selling
VCYT65.76%34.24%Net SellingNet Selling
MLTX73.62%26.38%Net Selling
APLS76.78%23.22%Net SellingNet Selling
View Top Biotech Stocks

Immunovant Stock Ownership FAQ

Who owns Immunovant?

Immunovant (NASDAQ: IMVT) is owned by 48.45% institutional shareholders, 59.93% Immunovant insiders, and 0.00% retail investors. Roivant Sciences Ltd is the largest individual Immunovant shareholder, owning 96.65M shares representing 56.90% of the company. Roivant Sciences Ltd's Immunovant shares are currently valued at $1.40B.

If you're new to stock investing, here's how to buy Immunovant stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.